<DOC>
	<DOCNO>NCT01486381</DOCNO>
	<brief_summary>This trial conduct South Africa . The aim trial investigate Long term safety biphasic insulin aspart 30 juvenile type 1 diabetes previously treat trial BIAsp-1240 .</brief_summary>
	<brief_title>Long Term Safety Biphasic Insulin Aspart 30 Juveniles With Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin aspart , insulin aspart protamine drug combination 30:70</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>Signed informed consent obtain trialrelated activity accord local requirement . ( Trialrelated activity procedure would perform normal management subject ) The subject must complete trial BIAsp1240</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>